Evidence map›Paper›PMID 38301109›Full record

ArticleArchives of Iranian medicine2023

PERSIAN Eye Cohort Study (PECS): Design, Methodology.

Fateme Alipour, Hassan Hashemi, Alireza Lashay, Fatemeh Jafari, Nazgol Motamed-Gorji, Mahmoud Jabbarvand Behrouz, Mohammad Mirzaei, Yousef Alizade, Mohammad Reza Soleymani, Mohammad Reza Shoja and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Archives of Iranian medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 1 country.

Fateme AlipourTranslational Ophthalmology Research Center, Farabi Eye Hospital, Department of Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-2851-2692
Hassan HashemiNoor Ophthalmology Research Center, Tehran, Iran.
Alireza LashayTranslational Ophthalmology Research Center, Farabi Eye Hospital, Department of Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-6409-4654
Fatemeh JafariTranslational Ophthalmology Research Center, Farabi Eye Hospital, Department of Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran.
Nazgol Motamed-GorjiDigestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mahmoud Jabbarvand BehrouzTranslational Ophthalmology Research Center, Farabi Eye Hospital, Department of Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad MirzaeiDepartment of Ophthalmology, Tabriz University of Medical Sciences, Tabriz, Iran.
Yousef AlizadeAmiralmomenin hospital, Department of ophthalmology, Gillan University of Medical Sciences, Rasht, Iran.
Mohammad Reza SoleymaniDepartment of Ophthalmology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Mohammad Reza ShojaDepartment of Ophthalmology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Kourosh ShahrakiDepartment of Ophthalmology, Zahedan University of Medical Sciences, Zahedan, Iran.
Gholam Reza KhataminiaDepartment of Ophthalmology, Jundishapur University of Medical Sciences, Ahvaz, Iran.
Hossein PoustchiLiver, Pancreatic, and Biliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Reza MalekzadehDigestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Farabi Hospital · IRShariati Hospital · IRAhvaz Jundishapur University of Medical Sciences · IRGuilan University of Medical Sciences · IRNoor Eye Hospital · IRRafsanjan University of Medical Sciences · IRShahid Sadoughi University of Medical Sciences and Health Services · IRTabriz University of Medical Sciences · IRTehran University of Medical Sciences · IRZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo report the study protocol, methodology and latest enrollment data of a large epidemiological multi-central eye cohort named PERSIAN Eye Cohort Study (PECS), originating from the ongoing PERSIAN Cohort Study, to investigate the distribution of ophthalmic disorders in different regions and ethnicities of Iran, and determine their associations with various exposures of ophthalmic and non-ophthalmic nature.

methodsA central committee designed the study and equipped six chosen centers (Khameneh, Some'e Sara, Hoveizeh, Yazd, Rafsanjan and Zahedan). A focal point in each center conducted the study under close supervision of the central committee.

resultsThis ongoing study was launched in 2014. Out of 65,580 eligible participants of the PERSIAN Cohort, 48,618 individuals aged 35-70 have been enrolled in the PECS (response rate: 74.13%) until June 2021. Slit lamp and fundus photography were performed for 28,702 (59.03%) and 27,437 (56.43%) individuals, respectively.

conclusionThis large epidemiological multi-central eye cohort can improve our epidemiological knowledge of the prevalent ophthalmic disorders in different regions and ethnicities of Iran, and determine their associations with various exposures of ophthalmic and non-ophthalmic nature. This will be very useful for future planned nationwide and global interventions.

Indexed as

Cohort StudiesHumansIranLongitudinal StudiesRisk FactorsCohort studyEpidemiologyIranOphthalmology

Identifiers

PMID38301109
PMCPMC10685732
OpenAlexW4388502702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.